Michele G Padovan1, Lucy V Norling1,2. 1. William Harvey Research Institute, Barts and the London School of Medicine. 2. Centre for Inflammation and Therapeutic Innovation, Queen Mary University of London, London, UK.
Abstract
PURPOSE OF REVIEW: Sepsis is a life-threatening condition caused by a dysregulated host response to infection that remains a huge clinical challenge. Recent evidence indicates that bioactive lipid mediators derived from polyunsaturated fatty acids termed specialized pro-resolving mediators (SPMs) are promising new candidates for treating critical illness. RECENT FINDINGS: We highlight herein the protective actions of SPMs in experimental sepsis, cardiac dysfunction, and also lung and cerebral injury, and discuss their mechanisms of action. We also emphasize that failed resolution responses and dysregulated SPM pathways may provide an explanation for the ongoing chronic inflammation in many diseases including chronic heart failure. SUMMARY: Importantly, monitoring plasma SPM profiles can predict patient outcomes in sepsis indicating their utility as new early biomarkers that may help stratify patients upon ICU admission.
PURPOSE OF REVIEW: Sepsis is a life-threatening condition caused by a dysregulated host response to infection that remains a huge clinical challenge. Recent evidence indicates that bioactive lipid mediators derived from polyunsaturated fatty acids termed specialized pro-resolving mediators (SPMs) are promising new candidates for treating critical illness. RECENT FINDINGS: We highlight herein the protective actions of SPMs in experimental sepsis, cardiac dysfunction, and also lung and cerebral injury, and discuss their mechanisms of action. We also emphasize that failed resolution responses and dysregulated SPM pathways may provide an explanation for the ongoing chronic inflammation in many diseases including chronic heart failure. SUMMARY: Importantly, monitoring plasma SPM profiles can predict patient outcomes in sepsis indicating their utility as new early biomarkers that may help stratify patients upon ICU admission.
Authors: Nan Chiang; Xavier de la Rosa; Stephania Libreros; Hui Pan; Jonathan M Dreyfuss; Charles N Serhan Journal: Proc Natl Acad Sci U S A Date: 2021-03-09 Impact factor: 11.205
Authors: Patricia R Souza; Mary E Walker; Nicolas J Goulding; Jesmond Dalli; Mauro Perretti; Lucy V Norling Journal: Front Immunol Date: 2020-09-29 Impact factor: 7.561
Authors: Daniel González-Hedström; Álvaro Moreno-Rupérez; María de la Fuente-Fernández; Mario de la Fuente-Muñoz; Marta Román-Carmena; Sara Amor; Ángel Luís García-Villalón; Asunción López-Calderón; Ana Isabel Martín; Teresa Priego; Miriam Granado Journal: Front Nutr Date: 2022-06-20
Authors: Bakr Jundi; Do-Hyun Lee; Hyungkook Jeon; Melody G Duvall; Julie Nijmeh; Raja-Elie E Abdulnour; Mayra Pinilla-Vera; Rebecca M Baron; Jongyoon Han; Joel Voldman; Bruce D Levy Journal: JCI Insight Date: 2021-08-09